MedTrace Logo

Evaluation of ADM(SC Derm® Recon) in Breast Reconstruction

NCT06553859 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-08-14

No results posted yet for this study

Summary

The goal of this observational study is to examine any clinical differences in the outcomes of breast reconstruction surgeries using Acellular Dermal Matrix (ADM) processed by CO2 supercritical fluid technology compared to other ADM products that have been washed with detergents. The study will also assess safety outcomes.

Conditions

  • Breast Cancer Female

Interventions

OTHER

No intervention conducts.

The type and method of breast reconstruction with sillicon implants and ADM implanting is now the standard treatment of breast cancer in korea. no any specific intervention has occurred during the surgery.

Sponsors & Collaborators

  • DOF Inc.

    lead INDUSTRY

Principal Investigators

  • Jinsup Um · Asan Medical Center

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-12
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06553859 on ClinicalTrials.gov